Tag: basal insulin

Clinical Trials, Research and Development

Novo Nordisk achieve headline results with icodec insulin

October 4, 2022

Via: Pharmaphorum

Compared to once-daily basal insulin (insulin degludec or insulin glargine U100/U300) analogues, the 52-week ONWARDS 5 trial – an open-label efficacy and safety treat-to-target study of 1,085 insulin-naïve people with type 2 diabetes in a clinical practice setting – achieved […]